McCaffrey, Nikki http://orcid.org/0000-0003-3684-3723
Asser, Tegan
Fazekas, Belinda
Muircroft, Wendy
Agar, Meera
Clark, Katherine
Eckermann, Simon
Lee, Jessica
Joshi, Rohit
Allcroft, Peter
Sheehan, Caitlin
Currow, David C.
Funding for this research was provided by:
Department of Health, Australian Government (N/A)
Article History
Received: 15 December 2019
Accepted: 21 October 2020
First Online: 31 October 2020
Ethics approval and consent to participate
: This PaCCSC RCT was approved by the following ethics committees across Australia (see ExternalRef removed).- Repatriation General Hospital Research and Ethics Committee, South Australia (EC00191)- Mater Health Services Human Research Ethics Committee, Mater Health Service, Queensland (EC00332)- Ballarat Health Services & St John of God Health Care Ethics Committee, Ballarat Health Services, Victoria (EC00326)- Alfred Hospital Ethics Committee, Victoria (EC00266)- Hollywood Private Hospital Research Ethics Committee, Western Australia (EC00266)- St John of God Health Care Ethics Committee, Western Australia (EC00414)- Peter MacCallum Cancer Centre Ethics Committee, Peter MacCallum Cancer Centre, Victoria (EC00235)Participants provided written informed consent.
: Not applicable.
: Professor Currow is an unpaid member of an advisory board for Helsinn Pharmaceuticals, is a consultant to Specialized Therapeutics and Mayne Pharma and received intellectual property payments from Mayne Pharma. All other authors declare no conflicts of interest.